ロード中...
Therapeutic vaccines in HBV: lessons from HCV
Currently, millions of people infected with hepatitis B virus (HBV) are committed to decades of treatment with anti-viral therapy to control viral replication. However, new tools for immunotherapy that include both viral vectors and molecular checkpoint inhibitors are now available. This has led to...
保存先:
| 出版年: | Med Microbiol Immunol |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4305103/ https://ncbi.nlm.nih.gov/pubmed/25573348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00430-014-0376-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|